miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease. - Wikidata - awgldk - TriplyDB

miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.

miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.

http://www.wikidata.org/entity/Q39223387

about

MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alveolar Bone Loss in Periodontal Disease MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment MicroRNAs in multiple myeloma and related bone disease MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation The role of miR-29b in cancer: regulation, function, and signaling Bone marrow stroma-derived miRNAs as regulators, biomarkers and therapeutic targets of bone metastasis MicroRNA: important player in the pathobiology of multiple myeloma Regulation of Matrix Metalloproteinase-2 Secretion from Scleral Fibroblasts and Retinal Pigment Epithelial Cells by miR-29a.Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.MicroRNAs are absorbed in biologically meaningful amounts from nutritionally relevant doses of cow milk and affect gene expression in peripheral blood mononuclear cells, HEK-293 kidney cell cultures, and mouse livers.MicroRNAs involved in bone formation.MicroRNAs Regulate Vascular Medial Calcification.NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.MicroRNA-26a regulates RANKL-induced osteoclast formation.In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.Loss of miRNAs during processing and storage of cow's (Bos taurus) milk.Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients.Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.The Intestinal Transport of Bovine Milk Exosomes Is Mediated by Endocytosis in Human Colon Carcinoma Caco-2 Cells and Rat Small Intestinal IEC-6 Cells.The role of microRNAs in osteoclasts and osteoporosis.Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.MicroRNAs' Involvement in Osteoarthritis and the Prospects for Treatments.Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.Gene regulation by dietary microRNAs.Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?MicroRNA functions in osteogenesis and dysfunctions in osteoporosis MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6.Human vascular endothelial cells transport foreign exosomes from cow's milk by endocytosis.In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma.miR-29 promotes murine osteoclastogenesis by regulating osteoclast commitment and migration Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.Aberrant microRNA expression in multiple myeloma.The role of notch signaling in bone marrow niche.Recent advances in the involvement of long non-coding RNAs in neural stem cell biology and brain pathophysiology.microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.MicroRNAs: New therapeutic targets for intestinal barrier dysfunction.MicroRNAs as regulators of bone homeostasis and bone metastasis.

P2860

Q26741214-45C46D84-C443-4C78-960E-6B6489705F7D Q26765477-257B4F38-4101-4F02-9A7F-450370078685 Q26770478-46177C07-ADAB-4FD1-92F5-3B33218D2B8E Q26783571-6EFB285E-0A62-4BD9-AC65-6492EC42DF37 Q26851543-7F0F5BCB-E93F-4FD6-A55F-7E72A84027C2 Q28087442-CBCE5318-8680-4E99-B1F8-E774FC700A76 Q33786861-583A4513-3F93-46B1-BC01-40CE5AFFD447 Q33787228-DC51A5D9-CC51-46D9-8025-F03420EFAEB5 Q33917555-7A05B2E0-25F9-4690-9A8F-F9E42F09DD9D Q34103347-D14CA4D5-43F3-4D01-955F-E70B69040F70 Q34171902-A4B75F0F-7F79-4091-A0F6-93F11E74C252 Q34527129-772A99C9-9720-4535-9C9C-DDDF7591D26E Q34774697-950EBBB0-EB1C-44ED-A148-2902E83FAA90 Q34912673-3678F64E-F2D2-434B-8B4D-78A3A2A0B88C Q35038986-BCB40AB8-9E0C-4986-BC09-6A172C18666F Q35108549-A6A03C1A-DA7C-4055-8227-89600461B2D5 Q35176387-917432E6-A0AF-4B8A-A420-A9BCBD0229A1 Q35294720-EE2411A5-C367-43D4-B1B6-9F22363A54EE Q35742519-742EB49A-0DAC-4285-8595-6148D1E7D208 Q35955440-4661A173-C6D5-4CFA-9829-1BBD2A58B76D Q36087851-4A2A133A-7A64-4C60-8246-34BA53E7A883 Q36190994-24A4EC34-E666-446B-B34E-0F321F20DBC0 Q36254566-54E707A1-E570-4777-8C84-2328BD4DCFE1 Q36261112-14F38843-F47A-4108-96A2-6207AE152B5F Q36413501-4CD572AC-84B8-4568-B6C6-052BD388874F Q36550667-E5052DC6-9042-45DE-A7FE-674D65DAE487 Q36860835-522D62CC-80AB-4155-AFF3-88367AC62EE0 Q36917893-F9C7BF96-0347-4B67-A0AE-B52EE6191F23 Q36952076-85D51183-882C-44DC-9048-0F863C95EEFF Q36975006-9844FCCD-046E-4EC0-8F5B-C1803FC4E498 Q37016562-5F8A7278-CAC8-4187-8A83-58DA97A90CFC Q37311447-4F3C00EF-98B3-41DE-BBE2-62E3D551703A Q37575983-ECF406E4-5CC0-4C69-9F63-5B3900099094 Q37619866-26352E0E-1209-4F0C-9082-8964FF4CCF8F Q38099048-754E5077-CA93-44A8-9C9C-2949A5CE33E8 Q38203927-3571C3D8-70AC-421C-837C-097552B9D913 Q38209316-DF0FD056-8079-4715-B002-24E0DA9EE4E0 Q38213075-49290626-F6E0-4D9C-A537-BAF695E19A38 Q38219024-C9C3DD94-0860-4626-A02E-56B99BDFD793 Q38239679-9D6369F6-A126-48C4-B6EE-1BB9FB586B9F

P2860

miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.

http://www.wikidata.org/entity/Q39223387

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

miR-29b negatively regulates h ...... myeloma-related bone disease.

@en

miR-29b negatively regulates h ...... myeloma-related bone disease.

@nl

type

label

miR-29b negatively regulates h ...... myeloma-related bone disease.

@en

miR-29b negatively regulates h ...... myeloma-related bone disease.

@nl

prefLabel

miR-29b negatively regulates h ...... myeloma-related bone disease.

@en

miR-29b negatively regulates h ...... myeloma-related bone disease.

@nl

P1433

Q39223387-810DC228-32E2-4574-8098-7B46BDEC12E9

P1476

Q39223387-F320DC82-5400-4D78-A342-69A1F49F9E03

P2093

Q39223387-0694AD7F-39EE-44E5-BAE5-679737E0D7F5

Q39223387-2FC4FF83-B1E8-4CE9-A3E0-0B56C16901AC

Q39223387-30A15164-C2D5-4B57-B703-1872E028C2C4

Q39223387-32D4FBA5-D087-4677-857F-7A496E5BB310

Q39223387-8CD694FE-A590-43A0-B475-899566891A51

Q39223387-C6157385-8FA3-409E-87F9-C00757D52698

Q39223387-CC1BD3B7-49D3-413B-BA9C-A47A190D8177

Q39223387-E9FD241D-952A-4092-BB20-CD9B4325889D

Q39223387-FA5C5D45-7CB3-435D-B3BE-5584F612DB3C

Q39223387-FB73A818-A258-4FBF-9CA6-90E08CE5DDFF

P2860

Q39223387-0E1198FF-893C-45F2-A5C5-2ABA7E07437D

Q39223387-0F6C00F1-B21B-4452-BD1C-5106CB3725CA

Q39223387-12301B9B-7C37-4512-9B42-0C0F42C90CAA

Q39223387-13B4586F-CB26-404C-B718-4A08DAB36317

Q39223387-150D21C9-9175-46BD-A486-4631C5A5EC35

Q39223387-18A63E48-BB71-405C-9D2F-AA337B98F4DB

Q39223387-19E306E8-CE79-47C9-8C16-652BE01E334B

Q39223387-1C4D6DE2-C2C6-45E0-836C-F63BC9D62157

Q39223387-2FC49BED-60BB-44D6-8B2F-89FF7A723FA6

Q39223387-3AAB5B46-A43B-4E1A-AC83-143A09C1CEA8

P304

Q39223387-1EE7DA16-0A58-4D97-BBA8-B1409BA612BF

P31

Q39223387-AB037BF0-B06C-4BB1-ACF9-A977D3E20E02

P356

Q39223387-C05CF69E-BF9D-43A9-B1B1-E64D6BEAA5ED

P433

Q39223387-4F080C44-060E-4F64-96AE-B881108AF7DE

P478

Q39223387-173B482F-A937-4880-87D4-DADE5CED438F

P50

Q39223387-4B84C5BF-5A9C-4CAA-A1C3-08CDDA83C7BA

Q39223387-5F6ADB17-8ADF-41F4-AD76-E33D1FEBD3D5

Q39223387-87D31B43-2E01-4CBA-9689-D18D0EAD8D15

Q39223387-A3A5EF90-9707-4855-A3D3-D0EA7C8BD496

Q39223387-BB6F917B-C3CE-4A9B-811B-9CC8DCD1298C

P577

Q39223387-616C18B1-86F2-4615-8982-2E4D4CDA05C2

P5875

Q39223387-723BF9C6-17C6-455E-805D-F6881A4DEEE6

P698

Q39223387-C4FEE93C-C8E4-4C38-B7C9-FFBB1F483810

P356

P1433

Journal of Cellular Physiology

P1476

miR-29b negatively regulates h ...... myeloma-related bone disease.

@en

P2093

Eleonora Iuliano

http://www.w3.org/2001/XMLSchema#string

Emanuela Leone

http://www.w3.org/2001/XMLSchema#string

Francesco Conforti

http://www.w3.org/2001/XMLSchema#string

Francesco Maria Paolino

http://www.w3.org/2001/XMLSchema#string

Maria Rita Pitari

http://www.w3.org/2001/XMLSchema#string

Maria Teresa Di Martino

http://www.w3.org/2001/XMLSchema#string

Nicola Amodio

http://www.w3.org/2001/XMLSchema#string

Pierfrancesco Tassone

http://www.w3.org/2001/XMLSchema#string

Pierosandro Tagliaferri

http://www.w3.org/2001/XMLSchema#string

Teresa Del Giudice

http://www.w3.org/2001/XMLSchema#string

P2860

A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma

MicroRNAs: genomics, biogenesis, mechanism, and function

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

Regulation of type I collagen genes expression

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

MicroRNAs in Cancer

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

Molecular mechanisms of action of bisphosphonates.

The pharmacology of bisphosphonates and new insights into their mechanisms of action.

miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling

P304

1506-1515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.24306

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P50

Michele Caraglia

Manlio Ferrarini

Antonio Giordano

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233957940

http://www.w3.org/2001/XMLSchema#string

P698

23254643

http://www.w3.org/2001/XMLSchema#string